Targeted-delivery of chemotherapy (NANOLEUK) vs standard chemotherapy in acute myeloid leukemia: a proposed randomized, double-blinded, multicenter efficacy trial. (2016). Principles and Practice of Clinical Research, 2(2). https://journal.ppcr.org/index.php/ppcrjournal/article/view/44